Firma Fresenius SE & Co. KGaA, Autor bei PR-Web

Fresenius makes use of the relief payments for increased energy costs provided for in the Hospital Financing Act and promotes long-term strengthening of the company

Posted on 6. December 2023 by Firma Fresenius SE & Co. KGaA Posted in General Tagged clinical, company, currency, dividend, ebitda, energy, fiscal, fresenius, helios, market, medical, risks, statements, supervisory, with

Fresenius makes use of the governmental compensation and reimbursement payments of up to €300 million (from the current perspective) provided for in the relief package for compensating additional costs caused by the increase in energy prices and implements the […]

Fresenius successfully completes deconsolidation of Fresenius Medical Care

Posted on 30. November 2023 by Firma Fresenius SE & Co. KGaA Posted in General Tagged clinical, company, dialysis, fresenius, historic, IFRS, medical, patients, release, revenue, risks, shareholders, statements, treatment, with

Deconsolidation is a landmark in the implementation of the #FutureFresenius program and a historic day for both companies Reducing complexity is a prerequisite for greater flexibility as well as more efficient and faster decision-making and the basis for long-lasting […]

#FutureFresenius continues to provide positive momentum: Fresenius delivers strong third quarter performance and improves operating earnings outlook

Posted on 2. November 2023 by Firma Fresenius SE & Co. KGaA Posted in General Tagged currency, ebit, flat, fresenius, helios, IFRS, kabi, medical, new, organic, revenue, strong, trust, vamed, with

. – Excellent Group revenue growth of 6% in constant currency to €5.5 billion; driven by Operating Companies and Fresenius Vamed – Group EBIT increased 10% in constant currency, reflecting strong performance of Operating Companies; Fresenius Vamed with operational improvement […]

Fresenius appoints Robert Möller to the Management Board

Posted on 8. September 20238. September 2023 by Firma Fresenius SE & Co. KGaA Posted in General Tagged any, clinical, company, eugin, fresenius, healthcare, helios, medical, meo, patients, risks, statements, Stralsund, supervisory, with

. – Robert Möller appointed to the Fresenius Management Board; at the same time, Möller will assume responsibility for hospital group as CEO of Helios Health GmbH – Dr. Francesco De Meo leaves the company – Management Board team continues […]

Progress on #FutureFresenius: Operating Companies showing consistent performance

Posted on 2. August 2023 by Firma Fresenius SE & Co. KGaA Posted in General Tagged Aktien, ebit, fiscal, fresenius, helios, hfo, hte, kabi, kabis, market, patients, project, revenue, vamed, with

.  Excellent Group revenue growth of 7% in constant currency to €10.4 billion; Operating Companies with very strong 8% organic growth  Group EBIT increased 15%1 in constant currency reflecting strong performance of Operating Companies and operational turnaround at […]

Fresenius announces changes in the Management Board

Posted on 28. June 2023 by Firma Fresenius SE & Co. KGaA Posted in General Tagged ampc, board, doctor, financial, fresenius, healthcare, hennicken, krems, mba, medical, new, supervisory, vamed, with, wortmann

. • Dr. Ernst Wastler will leave the Fresenius Management Board upon reaching retirement age on July 18, 2023 • Changes and rejuvenation in the Management team of the Fresenius Vamed business segment • Strengthened control function through new appointments […]

Fresenius moves more than 130 SAP systems to the cloud – a digitalization milestone on its #FutureFresenius journey

Posted on 23. June 2023 by Firma Fresenius SE & Co. KGaA Posted in General Tagged 4hana, clinical, cloud, crm, erp, fresenius, logistics, market, patients, project, risks, SAP, security, statements, with

Fresenius has reached an important milestone in its IT transformation. The company successfully migrated its key SAP systems into the cloud with RISE with SAP, a comprehensive set of packages provided by SAP that helps companies transform into intelligent enterprises. […]

Fresenius SE hosts Kabi Capital Markets Day outlining pathway towards sustainable value creation in line with #FutureFresenius

Posted on 25. May 202325. May 2023 by Firma Fresenius SE & Co. KGaA Posted in General Tagged biosimilars, cell, contracting, ebit, ebitda, energy, enteral, fresenius, kabi, kabis, mabxience, market, patients, statements, with

. • Advancing patient care – Providing world-class health care products and therapies for the benefit of patients around the world • Serving highly attractive markets – Unique platform of four leading and complementary businesses in large, growing markets positions […]

Fresenius signs Diversity Charter

Posted on 23. May 202323. May 2023 by Firma Fresenius SE & Co. KGaA Posted in General Tagged clinical, company, fresenius, healthcare, helios, identity, measures, networks, origin, report, risks, scholz, statements, strong, with

Fresenius has signed the German "Charta der Vielfalt" (Diversity Charter). The healthcare group is thus taking a strong stance for diversity and inclusion in its own company. The Diversity Charter is an initiative to promote diversity in companies and institutions […]

Fresenius places sustainable Schuldschein loan of 850 million euros

Posted on 22. May 202322. May 2023 by Firma Fresenius SE & Co. KGaA Posted in General Tagged Asia, financial, fresenius, healthcare, hennicken, hessen, loan, may, proceeds, safety, sustainability, tranche, transaction, treatment, with

The healthcare group Fresenius has issued its first sustainability-linked Schuldschein loan with a volume of 850 million euros. It consists of 6 tranches with maturities of 3, 5 and 7 years, each offered with fixed and variable interest rates. The […]